← Leaderboards
Hassan Ashktorab
Howard University
$3,290,384
Attributed
$4,721,731
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $594.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,721,731 · 5
By mechanism
R01$4,400,065 · 2
R03$281,162 · 1
M01$40,504 · 1
U54$0 · 1
Top collaborators
- John M Carethers7 shared
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanLoss Of HeterozygosityClinical ResearchCaucasiansP53 Gene /ProteinColorectal CancerPhenotypeMutationProteinsGenesChromosomesMicrosatellite RepeatsCancer RiskMlh1 GeneMalignant NeoplasmsColon Cancer PatientsDna Double Strand BreakEthnic OriginInflammationCytosolCytokineAneuploidyClustered Regularly Interspaced Short Palindromic RepeatsDefect
Grant awards (21)
Inactivation of MSH3 in Colorectal Cancer and Race$572,176
R01 · FY2025 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$543,566
R01 · FY2024 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$50,985
R01 · FY2024 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$561,716
R01 · FY2023 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$438,121
R01 · FY2022 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$116,662
R01 · FY2022 · CA
Inactivation of MSH3 in Colorectal Cancer and Race$579,469
R01 · FY2021 · CA
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$251,476
R01 · FY2007 · CA · contact PI
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$82,880
R01 · FY2007 · CA · contact PI
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$258,987
R01 · FY2006 · CA · contact PI
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$82,880
R01 · FY2006 · CA · contact PI
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$265,220
R01 · FY2005 · CA
MSI$40,504
M01 · FY2005 · RR
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$265,220
R01 · FY2004 · CA
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$65,487
R01 · FY2004 · CA
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER$265,220
R01 · FY2003 · CA
Mechanisms of Growth Inhibition by Helicobacter Pylor$50,736
R03 · FY2003 · DK
Mechanisms of Growth Inhibition by Helicobacter Pylori$79,426
R03 · FY2002 · DK
Mechanisms of Growth Inhibition by Helicobacter Pylor$75,500
R03 · FY2002 · DK
Pilot--Genomic instability and gene silencing in colon cancer$0
U54 · FY2002 · CA
Mechanisms of Growth Inhibition by Helicobacter Pylori$75,500
R03 · FY2001 · DK